Europe — EMA
Nalmefene Biogaran
GNH USA supplies Nalmefene Biogaran (Nalmefene), an opioid antagonist for alcohol dependence. We provide sourcing and delivery. Request a quote today.
Request sourcing
What is Nalmefene?
Nalmefene, the active ingredient in Nalmefene Biogaran, is an opioid antagonist presented as an oral formulation for oral use. It is indicated for the treatment of alcohol dependence in adults who have a high drinking risk level. It works by modulating opioid receptors to reduce the reinforcing effects of alcohol.
GNH USA supplies Nalmefene Biogaran as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our supply chain adheres to international quality standards, ensuring product integrity from manufacturing to delivery.
What is Nalmefene used for?
Nalmefene is an opioid antagonist used in the management of alcohol‑related disorders.
Alcohol dependence: reduces alcohol consumption and helps maintain lower drinking levels in adults with high‑risk drinking patterns.
What are the side effects of Nalmefene?
Adverse reactions may occur with nalmefene treatment.
Common Side Effects: - Nausea - Dizziness - Headache - Fatigue
Serious or Rare Side Effects: - Hepatic injury (elevated transaminases, jaundice) - Severe allergic reactions (anaphylaxis, angioedema) - Suicidal ideation or severe mood changes
What precautions apply to Nalmefene?
Nalmefene should be used with careful clinical monitoring. - Liver function assessment: evaluate hepatic status before initiating therapy. - Alcohol consumption monitoring: regularly assess drinking patterns during treatment. - Concomitant opioid use: avoid or adjust opioids due to risk of withdrawal. - Pregnancy and lactation: safety not established; use only if benefits outweigh risks. - Renal impairment: dose adjustment may be required in severe cases. - Store at below 25°C: keep in the original pack, protect from moisture.
What does Nalmefene interact with?
Nalmefene may interact with other medicines; some combinations require avoidance while others need close monitoring.
Major Interactions (Avoid): - Opioid analgesics: may precipitate acute opioid withdrawal. - Strong CYP2D6 inhibitors: can increase nalmefene plasma levels.
Moderate Interactions (Monitor Closely): - Alcohol: concurrent use may diminish nalmefene efficacy. - CNS depressants (e.g., benzodiazepines): may enhance sedative effects. - CYP3A4 inducers: may reduce drug exposure.


